These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7440766)

  • 1. Mild analgesics as an alternative to ergotamine in migraine. A comparative trial with acetylsalicylic acid, ergotamine tartrate, and a dextropropoxyphene compound.
    Hakkarainen H; Quiding H; Stockman O
    J Clin Pharmacol; 1980 Oct; 20(10):590-5. PubMed ID: 7440766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative trail of ergotamine tartrate, acetyl salicylic acid and a dextropropoxyphene compound in acute migraine attacks.
    Hakkarainen H; Gustafsson B; Stockman O
    Headache; 1978 Mar; 18(1):35-9. PubMed ID: 348645
    [No Abstract]   [Full Text] [Related]  

  • 3. Tolfenamic acid is as effective as ergotamine during migraine attacks.
    Hakkarainen H; Vapaatalo H; Gothoni G; Parantainen J
    Lancet; 1979 Aug; 2(8138):326-8. PubMed ID: 89390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks.
    Le Jeunne C; Gómez JP; Pradalier A; Titus i Albareda F; Joffroy A; Liaño H; Henry P; Lainez JM; Geraud G
    Eur Neurol; 1999 Jan; 41(1):37-43. PubMed ID: 9885327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled clinical trial of ergotamine tartrate.
    Waters WE
    Br Med J; 1970 May; 2(5705):325-7. PubMed ID: 4913961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in the intensity of abortive migraine drug use during coumarin therapy.
    Rahimtoola H; Egberts AC; Buurma H; Tijssen CC; Leufkens HG
    Headache; 2001 Sep; 41(8):768-73. PubMed ID: 11576200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naproxen sodium versus ergotamine tartrate in the treatment of acute migraine attacks.
    Treves TA; Streiffler M; Korczyn AD
    Headache; 1992 Jun; 32(6):280-2. PubMed ID: 1399547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ergotamine vs. metoclopramide vs. their combination in acute migraine attacks.
    Hakkarainen H; Allonen H
    Headache; 1982 Jan; 22(1):10-2. PubMed ID: 17152739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute migraine attack therapy: comparison of naproxen sodium and an ergotamine tartrate compound.
    Pradalier A; Rancurel G; Dordain G; Verdure L; Rascol A; Dry J
    Cephalalgia; 1985 Jun; 5(2):107-13. PubMed ID: 3926322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysine-acetylsalicylic acid in acute migraine attacks.
    Limmroth V; May A; Diener H
    Eur Neurol; 1999; 41(2):88-93. PubMed ID: 10023111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo-controlled double-blind trial of pirprofen and an ergotamine tartrate compound in migraine attacks.
    Kinnunen E; Erkinjuntti T; Färkkilä M; Palomäki H; Porras J; Teirmaa H; Freudenthal Y; Andersson P
    Cephalalgia; 1988 Sep; 8(3):175-9. PubMed ID: 3143482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesic efficacy and safety comparison of ketorolac tromethamine and Doleron for the alleviation of orthopaedic post-operative pain.
    Johansson S; Josefsson G; Malstam J; Lindstrand A; Stenstroem A
    J Int Med Res; 1989; 17(4):324-32. PubMed ID: 2676649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study.
    Geraud G; Compagnon A; Rossi A;
    Eur Neurol; 2002; 47(2):88-98. PubMed ID: 11844897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison.
    Diener HC; Jansen JP; Reches A; Pascual J; Pitei D; Steiner TJ;
    Eur Neurol; 2002; 47(2):99-107. PubMed ID: 11844898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group.
    Eur Neurol; 1991; 31(5):314-22. PubMed ID: 1653139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine.
    Christie S; Göbel H; Mateos V; Allen C; Vrijens F; Shivaprakash M;
    Eur Neurol; 2003; 49(1):20-9. PubMed ID: 12464714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migraine--treatment of acute attack.
    Wilkinson M
    Scott Med J; 1985 Oct; 30(4):258-62. PubMed ID: 3938068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined low-dose acetylsalicylic acid and dihydroergotamine in migraine prophylaxis. A double-blind, placebo-controlled crossover study.
    Bousser MG; Chick J; Fuseau E; Soisson T; Thevenet R
    Cephalalgia; 1988 Sep; 8(3):187-92. PubMed ID: 3197098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylsalicylic acid effervescent 1000 mg (Aspirin) in acute migraine attacks; a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study.
    Lange R; Schwarz JA; Hohn M
    Cephalalgia; 2000 Sep; 20(7):663-7. PubMed ID: 11128825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A practical guide to the management and prevention of migraine.
    Diener HC; Kaube H; Limmroth V
    Drugs; 1998 Nov; 56(5):811-24. PubMed ID: 9829155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.